R
Recursion Pharmaceuticals, Inc. (RXRX)
2.94
0.00 (0.00%)
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
2.94
0.00 (0.00%)
This stock has a consensus price target of $10.63 based on the ratings of 9 analysts. The high is $33.00 and the low is $5.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 5 | $ 10.63 | $ 33 |
| O’zgarish | 70.07% | 261.56% | 1022.45% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-02-26 | 104.08% | B of A Securities | $7 → $6 | Maintains | Neutral |
| 2026-02-26 | 172.11% | Needham | $8 → $8 | Reiterates | Buy |
| 2025-12-17 | 274.15% | JP Morgan | $10 → $11 | Upgrades | Neutral → Overweight |
| 2025-09-11 | 172.11% | Needham | $8 → $8 | Reiterates | Buy |
| 2025-07-08 | 172.11% | Needham | $8 → $8 | Reiterates | Buy |